JL
JI Lopez
Biobizkaia Health Research Institute, University of the Basque Country, Universidad Complutense de Madrid, 12 October University Hospital, Hospital Universitario Cruces
Research areas: Medicine · Surgery · Renal cell carcinoma treatment · Bladder and Urothelial Cancer Treatments · Urinary and Genital Oncology Studies
Employment
-
Biobizkaia Health Research Institute IP2022 - Present
-
University of the Basque Country Professor2011 - 2019
-
Hospital Universitario Cruces Chairman2007 - 2022
-
University of the Basque Country Associate professor1989 - 2011
-
Basurto University Hospital Staff pathologist1988 - 2007
-
Marina Baixa Hospital Staff pathologist1988 - 1988
Education
- 1984 - 1991
-
12 October University Hospital Pathologist1984 - 1988
-
University of the Basque Country Bachelor1976 - 1982
Projects & Funding
Projects & funding information is unavailable.
Publications (378)
- Fibroblast Activation Protein Alpha (FAP) Expression Is Associated with Disease Recurrence and Poor Response to Tyrosine Kinase Inhibitors in Advanced Clear Cell Renal Cell Carcinoma Save
- Duration of Menopause, Rather than Primary Hyperparathyroidism Severity, Predicts Osteoporosis in Postmenopausal Women: A Pilot Study from a Spanish Reference Center Save
- Migratory responses in enucleated cells: The forces driving the locomotion movement of unicellular organisms Save
- Hot Spots in Urogenital Basic Cancer Research and Clinics Save
- Prognostic and Therapeutic Implications of Alamandine Receptor MrgD Expression in Clear Cell Renal Cell Carcinoma with Development of Metastatic Disease Save
- Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy Save
- Revisiting Pulmonary Sclerosing Pneumocytoma Save
- B7-H3: a robust target for immunotherapy in prostate cancer Save
- Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients Save
- The Stay-Or-Leave Dilemma of Cells in Punctuated Tumors Save
- Clear Cell Renal Cell Carcinoma: A Test Bench for Investigating Tumor Complexity Save
- The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy Save
- Convergent insights into intratumor heterogeneity Save
- Palisading adenocarcinoma. Case report on a newly recognized tumor in the salivary glands. Save
- The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy Save
- Early Evolution in Cancer: A Mathematical Support for Pathological and Genomic Evidence in Clear Cell Renal Cell Carcinoma Save
- Distinct spatial landscapes in clear cell renal cell carcinoma as revealed by whole transcriptome analysis Save
- Benign Mesothelial Proliferations of the Tunica Vaginalis Testis Save
- Deep learning approach for accurate prostate cancer identification and stratification using combined immunostaining of cytokeratin, p63, and racemase. Save
- Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study. Save